Status:

COMPLETED

Lactoferrin Versus Iron Supplement in Irondeficiency Anemia and Weight Loss in Obese Children

Lead Sponsor:

Ain Shams University

Conditions:

Obesity, Childhood

Eligibility:

All Genders

6-12 years

Phase:

PHASE4

Brief Summary

The effect of lactoferrin versus iron supplement in treating iron deficiency anemia and helping weight loss in obese school age children

Detailed Description

Comparing iron versus lactoferrin as regard iron defiency anemia and weight loss in obese children

Eligibility Criteria

Inclusion

  • 1\. children age will be between 6 -12 years old. 2. Presence of iron deficiency anemia, it will be diagnosed by
  • CBC \>\> Hemoglobin level concentration below 11.5 g/dl.
  • level of serum iron is below 30 µmol/l,
  • level of ferritin is below 15 µg/dl
  • Total iron binding capacity is more 480 µg/dlL. 3. children should be stable and free from chronic disease. 4. Body Mass index (BMI) should be ≥the 95th percentile for children and teens of the same age and sex.
  • 5\. there is not history of iron supplements in the 3 months before treatment.

Exclusion

  • Father/mother refuses to participate in the study.
  • Hospitalized patient.
  • Non-anemic patient.
  • Patients receiving iron supplements 3 months before enrollment.
  • Patients with chronic diseases.
  • personal or family history of allergy to cow's milk or infant formula, eczema, moderate-to-severe allergic rhinitis or asthma, or milk intolerance.
  • severe anemia as Hemoglobin level concentration below 7 g/dl.

Key Trial Info

Start Date :

October 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2019

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04014855

Start Date

October 1 2018

End Date

July 1 2019

Last Update

July 10 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Marian Girgis Rizk Abdelsayed

Cairo, Non-US/Non-Canadian, Egypt, 02